［1］SUNG H,FERLAY J,SIEGEL RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries［J］.CA Cancer J Clin,2021,71(3):209-249.
［2］KADARA H,SCHEET P,WISTUBA II,et al.Early events in the molecular pathogenesis of lung cancer［J］.Cancer Prev Res,2016,9(7):518-527.
［3］UEMATSU K,HE B,YOU L,et al.Activation of the Wnt pathway in non small cell lung cancer:evidence of dishevelled overexpression［J］.Oncogene,2003,22(46):7218-7221.
［4］SAINTIGNY P,BURGER JA.Recent advances in non-small cell lung cancer biology and clinical management［J］.Discov Med,2012,13(71):287-297.
［5］MIN HY,LEE HY.Mechanisms of resistance to chemotherapy in non-small cell lung cancer［J］.Arch Pharm Res,2021,44(3):146-164.
［6］SIEGEL RL,MILLER KD,WAGLE NS,et al.Cancer statistics,2023［J］.CA Cancer J Clin,2023,73(1):17-48.
［7］STEWART DJ.Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer［J］.Crit Rev Oncol Hematol,2010,75(3):173-234.
［8］LI F,CHONG ZZ,MAIESE K.Winding through the Wnt pathway during cellular development and demise［J］.Histol Histopathol,2006,21(1):103-124.
［9］MACDONALD BT,HE X.Frizzled and LRP5/6 receptors for Wnt/β-catenin signaling［J］.Cold Spring Harb Perspect Biol,2012,4(12):a007880.
［10］SHANG S,HUA F,HU ZW.The regulation of β-catenin activity and function in cancer:therapeutic opportunities［J］.Oncotarget,2017,8(20):33972-33989.
［11］RANES M,ZALESKA M,SAKALAS S,et al.Reconstitution of the destruction complex defines roles of AXIN polymers and APC in β-catenin capture,phosphorylation,and ubiquitylation［J］.Mol Cell,2021,81(16):3246-3261.
［12］VLADAR EK,KNIGSHOFF M.Noncanonical Wnt planar cell polarity signaling in lung development and disease［J］.Biochem Soc Trans,2020,48(1):231-243.
［13］PARSONS MJ,TAMMELA T,DOW LE.Wnt as a driver and dependency in cancer［J］.Cancer Discov,2021,11(10):2413-2429.
［14］VAUGHAN AE,HALBERT CL,WOOTTON SK,et al.Lung cancer in mice induced by the jaagsiekte sheep retrovirus envelope protein is not maintained by rare cancer stem cells,but tumorigenicity does correlate with Wnt pathway activation［J］.Mol Cancer Res,2012,10(1):86-95.
［15］PACHECO-PINEDO EC,DURHAM AC,STEWART KM,et al.Wnt/β-catenin signaling accelerates mouse lung tumorigenesis by imposing an embryonic distal progenitor phenotype on lung epithelium［J］.J Clin Invest,2011,121(5):1935-1945.
［16］LEMJABBAR-ALAOUI H,DASARI V,SIDHU SS,et al.Wnt and hedgehog are critical mediators of cigarette smoke-induced lung cancer［J］.PLoS One,2006,1(1):e93.
［17］SAKURAI R,CERNY LM,TORDAY JS,et al.Mechanism for nicotine-induced up-regulation of Wnt signaling in human alveolar interstitial fibroblasts［J］.Exp Lung Res,2011,37(3):144-154.
［18］LI Y,SHEU CC,YE Y,et al.Genetic variants and risk of lung cancer in never smokers:a genome-wide association study［J］.Lancet Oncol,2010,11(4):321-330.
［19］ANASTAS JN,MOON RT.Wnt signalling pathways as therapeutic targets in cancer［J］.Nat Rev Cancer,2013,13(1):11-26.
［20］DRIESSENS G,ZHENG Y,LOCKE F,et al.Beta-catenin inhibits T cell activation by selective interference with linker for activation of T cells-phospholipase C-γ1 phosphorylation［J］.J Immunol,2011,186(2):784-790.
［21］YE L,LI H,WANG H,et al.Abnormal β-catenin expression and reduced tumor-infiltrating T cells are related to poor progression in non-small cell lung cancer［J］.Int J Clin Exp Pathol,2017,10(12):11572-11579.
［22］GAO C,WANG Y,BROADDUS R,et al.Exon 3 mutations of CTNNB1 drive tumorigenesis:a review［J］.Oncotarget,2018,9(4):5492-5508.
［23］GIANGRECO A,LU L,VICKERS C,et al.β-catenin determines upper airway progenitor cell fate and preinvasive squamous lung cancer progression by modulating epithelial-mesenchymal transition［J］.J Pathol,2012,226(4):575-587.
［24］HANAHAN D,WEINBERG RA.Hallmarks of cancer:the next generation［J］.Cell,2011,144(5):646-674.
［25］RAMJIAWAN RR,GRIFFIOEN AW,DUDA DG.Anti-angiogenesis for cancer revisited:is there a role for combinations with immunotherapy［J］.Angiogenesis,2017,20(2):185-204.
［26］DEJANA E.The role of Wnt signaling in physiological and pathological angiogenesis［J］.Circ Res,2010,107(8):943-952.
［27］HEUBERGER J,BIRCHMEIER W.Interplay of cadherin-mediated cell adhesion and canonical Wnt signaling［J］.Cold Spring Harb Perspect Biol,2010,2(2):a002915.
［28］QI J,WANG J,ROMANYUK O,et al.Involvement of Src family kinases in N-cadherin phosphorylation and beta-catenin dissociation during transendothelial migration of melanoma cells［J］.Mol Biol Cell,2006,17(3):1261-1272.
［29］DVORAK HF.Tumor stroma,tumor blood vessels,and antiangiogenesis therapy［J］.Cancer J,2015,21(4):237-243.
［30］HE W,LU Q,SHERCHAN P,et al.Activation of frizzled-7 attenuates blood-brain barrier disruption through Dvl/β-catenin/WISP1 signaling pathway after intracerebral hemorrhage in mice［J］.Fluids Barriers CNS,2021,18(1):44.
［31］RAPP J,KISS E,MEGGYES M,et al.Increased Wnt5a in squamous cell lung carcinoma inhibits endothelial cell motility［J］.BMC Cancer,2016,16(1):915.
［32］ZHANG XX,ZHANG LL,YANG HL,et al.Mechanism of Wnt/β-catenin signaling pathway in enhanced malignant phenotype of non-small cell lung cancer induced by anti-angiogenesis therapy［J］.Asian Pac J Trop Med,2016,9(1):58-62.
［33］VICENTE-DUEAS C,HAUER J,RUIZ-ROCA L,et al.Tumoral stem cell reprogramming as a driver of cancer:theory,biological models,implications in cancer therapy［J］.Semin Cancer Biol,2015,32:3-9.
［34］SCLAFANI RA,SCHAUER IE.Cell cycle control and cancer:lessons from lung cancer［J］.J Investig Dermatol Symp Proc,1996,1(2):123-127.
［35］BRETONES G,DELGADO MD,LEN J.Myc and cell cycle control［J］.Biochim Biophys Acta,2015,1849(5):506-516.
［36］MUZ-ESPN D,SERRANO M.Cellular senescence:from physiology to pathology［J］.Nat Rev Mol Cell Biol,2014,15(7):482-496.
［37］KATOH M, KATOH M.Wnt signaling pathway and stem cell signaling network［J］.Clin Cancer Res,2007,13(14):4042-4045.
［38］MALLADI S,MACALINAO DG,JIN X,et al.Metastatic latency and immune evasion through autocrine inhibition of Wnt ［J］.Cell,2016,165(1):45-60.
［39］ISHII H,IWATSUKI M,IETA K,et al.Cancer stem cells and chemoradiation resistance［J］.Cancer Sci,2008,99(10):1871-1877.
［40］MILANOVIC M,FAN DNY,BELENKI D,et al.Senescence-associated reprogramming promotes cancer stemness［J］.Nature,2018,553(7686):96-100.
［41］KALLURI R,WEINBERG RA.The basics of epithelial-mesenchymal transition［J］.J Clin Invest,2009,119(6):1420-1428.
［42］YILMAZ M,CHRISTOFORI G.EMT,the cytoskeleton,and cancer cell invasion［J］.Cancer Metastasis Rev,2009,28(1-2):15-33.
［43］NAKAYAMA S,SNG N,CARRETERO J,et al.β-catenin contributes to lung tumor development induced by EGFR mutations［J］.Cancer Res,2014,74(20):5891-5902.
［44］LE S,YU M,YAN J.Phosphorylation reduces the mechanical stability of the α-catenin/ β-catenin complex［J］.Angew Chem Int Ed Engl,2019,58(51):18663-18669.
［45］OVERALL CM, KLEIFELD O.Tumour microenvironment-opinion:validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy［J］.Nat Rev Cancer,2006,6(3):227-239.
［46］BARRALLO-GIMENO A,NIETO MA.The Snail genes as inducers of cell movement and survival:implications in development and cancer［J］.Development,2005,132(14):3151-3161.
［47］BACHELDER RE,YOON SO,FRANCI C,et al.Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription:implications for the epithelial-mesenchymal transition［J］.J Cell Biol,2005,168(1):29-33.
［48］ZHANG Z,LIU J,LI H,et al.β-catenin signaling pathway regulates cisplatin resistance in lung adenocarcinoma cells by upregulating Bcl-xl［J］.Mol Med Rep,2016,13(3):2543-2551.
［49］LUO K,GU X,LIU J,et al.Inhibition of disheveled-2 resensitizes cisplatin-resistant lung cancer cells through down-regulating Wnt/β-catenin signaling［J］.Exp Cell Res,2016,347(1):105-113.
［50］ZHAO J,MA MZ,REN H,et al.Anti-HDGF targets cancer and cancer stromal stem cells resistant to chemotherapy［J］.Clin Cancer Res,2013,19(13):3567-3576.
［51］ZHENG H,NING Y,YANG Y,et al.Aberrant expression of β-catenin correlates with infiltrating immune cells and prognosis in NSCLC［J］.Pathol Oncol Res,2021,27:1609981.
［52］MUTO S,OZAKI Y,YAMAGUCHI H,et al.Tumor β-catenin expression is associated with immune evasion in non-small cell lung cancer with high tumor mutation burden［J］.Oncol Lett,2021,21(3):203.
［53］HERR P,HAUSMANN G,BASLER K.Wnt secretion and signalling in human disease［J］.Trends Mol Med,2012,18(8):483-493.
［54］LIU J,PAN S,HSIEH MH,et al.Targeting Wnt-driven cancer through the inhibition of porcupine by LGK974［J］.Proc Natl Acad Sci USA,2013,110(50):20224-20229.
［55］GURNEY A,AXELROD F,BOND CJ,et al.Wnt pathway inhibition via the targeting of frizzled receptors results in decreased growth and tumorigenicity of human tumors［J］.Proc Natl Acad Sci USA,2012,109(29):11717-11722.
［56］JIMENO A, GORDON M,CHUGH R,et al.A first-in-human phase istudy of the anticancer stem cell agent ipafricept (OMP-54F28),a decoy receptor for Wnt ligands,in patients with advanced solid tumors［J］.Clin Cancer Res,2017,23(24):7490-7497.
［57］HUANG SM,MISHINA YM,LIU S,et al.Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling［J］.Nature,2009,461(7264):614-620.
［58］YU H,XU L,LIU Z,et al.Circ_MDM2_000139,Circ_ATF2_001418,Circ_CDC25C_002079,and Circ_BIRC6_001271 are involved in the functions of XAV939 in non-small cell lung cancer［J］.Can Respir J,2019,2019:9107806.
［59］THORNE CA,HANSON AJ,SCHNEIDER J,et al.Small-molecule inhibition of Wnt signaling through activation of casein kinase 1α［J］.Nat Chem Biol,2010,6(11):829-836.
［60］ZHANG X,LOU Y,ZHENG X,et al.Wnt blockers inhibit the proliferation of lung cancer stem cells［J］.Drug Des Devel Ther,2015,9:2399-2407.
［61］ZHANG S,DA L,YANG X,et al.Celecoxib potentially inhibits metastasis of lung cancer promoted by surgery in mice,via suppression of the PGE2-modulated β-catenin pathway［J］.Toxicol Lett,2014,225(2):201-207.
［62］WATANABE K, DAI X.Winning Wnt:race to Wnt signaling inhibitors［J］.Proc Natl Acad Sci USA,2011,108(15):5929-5930.
［63］CHELTSOV A,NOMURA N,YENUGONDA VM,et al.Allosteric inhibitor of β-catenin selectively targets oncogenic Wnt signaling in colon cancer［J］.Sci Rep,2020,10(1):8096.
［64］TAKEUCHI Y,TANEGASHIMA T,SATO E,et al.Highly immunogenic cancer cells require activation of the Wnt pathway for immunological escape［J］.Sci Immunol,2021,6(65):eabc6424.
［65］ZHANG J,LAI W,LI Q,et al.A novel oncolytic adenovirus targeting Wnt signaling effectively inhibits cancer-stem like cell growth via metastasis,apoptosis and autophagy in HCC models［J］.Biochem Biophys Res Commun,2017,491(2):469-477.
［66］MARINEAU A,KHAN KA,SERVANT MJ.Roles of GSK-3 and β-catenin in antiviral innate immune sensing of nucleic acids［J］.Cells,2020,9(4):897.
［67］LEE JS,M.HUR W,LEE SK,et al.A novel sLRP6E1E2 inhibits canonical Wnt signaling,epithelial-to-mesenchymal transition,and induces mitochondria-dependent apoptosis in lung cancer［J］.PLoS One,2012,7(5):e36520.
［68］WANG Y,HUANG P,HU Y,et al.An oncolytic adenovirus delivering TSLC1 inhibits Wnt signaling pathway and tumor growth in SMMC-7721 xenograft mice model［J］.Acta Biochim Biophys Sin (Shanghai),2021,53(6):766-774.
［69］DENG QD,LEI XP,ZHONG YH,et al.Triptolide suppresses the growth and metastasis of non-small cell lung cancer by inhibiting β-catenin-mediated epithelial-mesenchymal transition［J］.Acta Pharmacol Sin,2021,42(9):1486-1497.
［70］TIAN Y,LI P,XIAO Z,et al.Triptolide inhibits epithelial-mesenchymal transition phenotype through the p70S6k/GSK3/β-catenin signaling pathway in taxol-resistant human lung adenocarcinoma［J］.Transl Lung Cancer Res,2021,10(2):1007-1019.
［71］RENO TA, TONG SW,WU J,et al.The triptolide derivative MRx102 inhibits Wnt pathway activation and has potent anti-tumor effects in lung cancer［J］.BMC Cancer,2016,16:439.
［72］WU C,ZHUANG Y,JIANG S,et al.Cinnamaldehyde induces apoptosis and reverses epithelial-mesenchymal transition through inhibition of Wnt/β-catenin pathway in non-small cell lung cancer［J］.Int J Biochem Cell Biol,2017,84:58-74.
［73］TONG Y,LIU Y,ZHENG H,et al.Artemisinin and its derivatives can significantly inhibit lung tumorigenesis and tumor metastasis through Wnt/β-catenin signaling［J］.Oncotarget,2016,7(21):31413-31428.
［74］WANG HQ,JIN JJ,WANG J.Matrine induces mitochondrial apoptosis in cisplatin-resistant non-small cell lung cancer cells via suppression of β-catenin/survivin signaling［J］.Oncol Rep,2015,33(5):2561-2566.
［75］TONG JB,ZHANG XX,WANG XH,et al.Qiyusanlong decoction suppresses lung cancer in mice via Wnt/β-catenin pathway［J］.Mol Med Rep,2018,17(4):5320-5327.
［76］PAI SG,CARNEIRO BA,MOTA JM,et al.Wnt/beta-catenin pathway:modulating anticancer immune response［J］.J Hematol Oncol,2017,10(1):101.
［77］WANG B,TIAN T,KALLAND KH,et al.Targeting Wnt/β-catenin signaling for cancer immunotherapy［J］.Trends Pharmacol Sci,2018,39(7):648-658.
［78］SURYAWANSHI A,MANICASSAMY S.Tumors induce immune tolerance through activation of β-catenin/TCF4 signaling in dendritic cells:a novel therapeutic target for cancer immunotherapy［J］.Oncoimmunology,2015,4(12):e1052932.
［79］SARODE P,ZHENG X,GIOTOPOULOU GA,et al.Reprogramming of tumor-associated macrophages by targeting β-catenin/FOSL2/ARID5A signaling:a potential treatment of lung cancer［J］.Sci Adv,2020,6(23):eaaz6105.